We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $5.13B
1-Year Est. Return 11.51%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+11.51%
3 Year Est. Return
+68.19%
5 Year Est. Return
+90.4%
10 Year Est. Return
+384.43%
AUM
$2.85B
AUM Growth
+$49.7M
Cap. Flow
-$75.2M
Cap. Flow %
-2.64%
Top 10 Hldgs %
41.46%
Holding
236
New
11
Increased
27
Reduced
106
Closed
12

Top Buys

Rank Stock Value
1
LUMN icon
Lumen
LUMN
+$11.8M
2
CACC icon
Credit Acceptance
CACC
+$5.56M
3
RDNT icon
RadNet
RDNT
+$4.84M
4
EPD icon
Enterprise Products Partners
EPD
+$3.54M
5
WAB icon
Wabtec
WAB
+$2.7M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$28.9M
2
QCOM icon
Qualcomm
QCOM
+$10M
3
DOV icon
Dover
DOV
+$6.22M
4
ABT icon
Abbott
ABT
+$3.3M
5
BX icon
Blackstone
BX
+$2.94M

Sector Composition

Rank Sector Weight
1 Financials 30.92%
2 Healthcare 16.7%
3 Technology 13.21%
4 Communication Services 10.46%
5 Industrials 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GE icon
126
GE Aerospace
GE
$319B
$737K 0.03%
14,082
+1,665
+13% +$82K
GLW icon
127
Corning
GLW
$124B
$728K 0.03%
21,905
– –
ADP icon
128
Automatic Data Processing
ADP
$110B
$719K 0.03%
4,351
– –
FLS icon
129
Flowserve
FLS
$9.03B
$704K 0.02%
13,362
– –
CHCO icon
130
City Holding Co
CHCO
$2.04B
$698K 0.02%
9,159
-700
-7% -$53.9K
IDXX icon
131
Idexx Laboratories
IDXX
$40.2B
$675K 0.02%
2,450
– –
CL icon
132
Colgate-Palmolive
CL
$69.4B
$664K 0.02%
9,259
-40,800
-82% -$2.9M
UNH icon
133
UnitedHealth
UNH
$337B
$660K 0.02%
2,703
-69
-2% -$16.6K
FTV icon
134
Fortive
FTV
$17B
$638K 0.02%
12,420
– –
HES
135
DELISTED
Hess
HES
$636K 0.02%
10,000
– –
CELG
136
DELISTED
Celgene Corp
CELG
$632K 0.02%
6,837
-340
-5% -$32.3K
EMR icon
137
Emerson Electric
EMR
$82B
$625K 0.02%
9,370
– –
LBRDK
138
DELISTED
Liberty Broadband Class C
LBRDK
$600K 0.02%
5,761
– –
JPM.PRC icon
139
JPMorgan Chase & Co 6.00% Series EE Preferred Stock
JPM.PRC
$1.76B
$560K 0.02%
+20,622
New +$550K
CVS icon
140
CVS Health
CVS
$121B
$544K 0.02%
9,977
-1,900
-16% -$102K
TMM
141
DELISTED
GRUPO TMM S.A.B. ADS REPTG FIVE ORD PART CERT SER A SH
TMM
$538K 0.02%
311,060
– –
PM icon
142
Philip Morris
PM
$303B
$483K 0.02%
6,150
-1,500
-20% -$124K
SCHH icon
143
Schwab US REIT ETF
SCHH
$11B
$478K 0.02%
21,500
– –
FAST icon
144
Fastenal
FAST
$56.7B
$456K 0.02%
28,000
– –
WBA
145
DELISTED
Walgreens Boots Alliance
WBA
$454K 0.02%
8,313
– –
MKC icon
146
McCormick & Company Non-Voting
MKC
$13.4B
$452K 0.02%
5,834
-200
-3% -$15.4K
NVS icon
147
Novartis
NVS
$263B
$443K 0.02%
4,850
-4,692
-49% -$397K
IRM icon
148
Iron Mountain
IRM
$33.4B
$442K 0.02%
14,124
– –
ROG icon
149
Rogers Corp
ROG
$2.34B
$431K 0.02%
2,500
– –
SUBC
150
DELISTED
SUBSEA 7 S A SPONSORED ADR
SUBC
$417K 0.01%
34,600
-604
-2% -$7.28K
4 5
6
7 8

Similar funds

ACM
AKRE Capital Management Middleburg, Virginia $5.12B AUM 19.08% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5.14B AUM 6.88% 1-Year Est. Return
CFO
Callan Family Office Radnor, Pennsylvania $5.11B AUM 35.28% 1-Year Est. Return
SB
SIG Brokerage New York $5.15B AUM 78.53% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $5.1B AUM 214.22% 1-Year Est. Return
KACA
Kayne Anderson Capital Advisors Los Angeles, California $5.1B AUM 17.16% 1-Year Est. Return

Beck Mack & Oliver's Q2 2019 Portfolio in Review

As of Q2 2019, Beck Mack & Oliver held 236 positions worth $2.85B, up 1.8% from $2.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Beck Mack & Oliver's Q2 2019 filing shows 11 new, 27 increased, 106 reduced and 12 closed positions. Its largest new stake was Focus Financial Partners Inc. Class A: 31,150 shares worth $851K. The largest sale was Teva Pharmaceuticals, an estimated $28.9M.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Technology.

  • Beck Mack & Oliver's largest Q2 2019 buy was Focus Financial Partners Inc. Class A: 31,150 shares worth $851K.
  • Beck Mack & Oliver added most to Lumen in Q2 2019, an estimated $11.8M increase.
  • Beck Mack & Oliver's biggest Q2 2019 reduction was Teva Pharmaceuticals, cutting an estimated $28.9M.
  • Beck Mack & Oliver fully exited Unilever NV New York Registry Shares in Q2 2019, selling an estimated $656K.
  • Beck Mack & Oliver's ten largest holdings make up 41% of its $2.85B portfolio in Q2 2019.
  • Beck Mack & Oliver opened 11 new positions and closed 12 in Q2 2019.
  • Beck Mack & Oliver's portfolio value rose 1.8% quarter-over-quarter to $2.85B.

Based on Beck Mack & Oliver's 13F filing for Q2 2019, filed 13 Aug 2019.